Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Maria Carmen Mir

Showing results (1-10 of 70) with videos related to

Pageof 7
Sort By:
European Urology|May 22, 2025
Re: Abdominal Noncontrast Computed Tomography Scanning to Screen for Kidney Cancer and Other Abdominal Pathology Within Community-based Computed Tomography Screening for Lung Cancer: Results of the Yorkshire Kidney Screening TrialTeele Kuusk, Maria Carmen Mir
BJU International|September 21, 2023
Is solo indocyanine green-guided lymphadenectomy a feasible alternative to standard pelvic lymph node dissection?Javier Perez-Ardavin, Maria Carmen Mir
European Urology|July 13, 2023
Re: Toni K. Choueiri, Thomas Powles, Laurence Albiges, et al. Cabozantinib plus Nivolumab and Ipilimumab in Renal-Cell Carcinoma. N Engl J Med 2023;388:1767-78Clara Cerrato, Benjamin Pradere, Maria Carmen Mir
Asian Journal of Urology|November 12, 2021
Molecular markers of systemic therapy response in urothelial carcinomaFrancesco Claps, Maria Carmen Mir, Homayoun Zargar
European Urology|March 26, 2023
Results from HIVEC-II for Intermediate-risk Non-muscle-invasive Bladder Cancer: Is This a Dead End for Mitomycin C Hyperthermia?Clara Cerrato, Morgan Roupret, Maria Carmen Mir
European Urology Oncology|November 19, 2025
Circulating Tumor DNA in Muscle-invasive Bladder Cancer: Promise, Pitfalls, and Path ForwardClara Cerrato, Morgan Rouprêt, Maria Carmen Mir
European Urology|April 2, 2013
Words of wisdom: Re: Precise segmental renal artery clamping under the guidance of dual-source computed tomography angiography during laparoscopic partial nephrectomyMaria Carmen Mir, Rebecca Campbell, Steven C Campbell
Urology|June 10, 2014
Editorial commentSteven C Campbell, Maria Carmen Mir, Toshio Takagi
European Urology|May 23, 2017
Reply to Jae Heon Kim and Benjamin I. Chung's Letter to the Editor re: Maria Carmen Mir, Ithaar Derweesh, Francesco Porpiglia, Homayoun Zargar, Alexandre Mottrie, Riccardo Autorino. Partial Nephrectomy Versus Radical Nephrectomy for Clinical T1b and T2 Renal Tumors: A Systematic Review and Meta-analysis of Comparative Studies. Eur Urol 2017;71:606-17Maria Carmen Mir, Ithaar H Derweesh, Riccardo Autorino
European Urology Oncology|April 4, 2026
Re: Bertolo R, Pastore AL, Verze P, et al. Real-world Burden and Management of Late Genitourinary Toxicity after Prostate Radiotherapy: Insights from IRRADIaTE, the Italian Registry of Radiotherapy-associated Disorders and Urological Treatment & Evaluation. Eur Urol Oncol. In press. http://dx.doi.org/10.1016/j.euo.2026.01.005Shilpa Gupta, Maria Carmen Mir, Daniel E Spratt
Pageof 7

Showing results (1-10 of 70) with videos related to

Sort By:
Pageof 7
European Urology|May 22, 2025
Re: Abdominal Noncontrast Computed Tomography Scanning to Screen for Kidney Cancer and Other Abdominal Pathology Within Community-based Computed Tomography Screening for Lung Cancer: Results of the Yorkshire Kidney Screening TrialTeele Kuusk, Maria Carmen Mir
BJU International|September 21, 2023
Is solo indocyanine green-guided lymphadenectomy a feasible alternative to standard pelvic lymph node dissection?Javier Perez-Ardavin, Maria Carmen Mir
European Urology|July 13, 2023
Re: Toni K. Choueiri, Thomas Powles, Laurence Albiges, et al. Cabozantinib plus Nivolumab and Ipilimumab in Renal-Cell Carcinoma. N Engl J Med 2023;388:1767-78Clara Cerrato, Benjamin Pradere, Maria Carmen Mir
Asian Journal of Urology|November 12, 2021
Molecular markers of systemic therapy response in urothelial carcinomaFrancesco Claps, Maria Carmen Mir, Homayoun Zargar
European Urology|March 26, 2023
Results from HIVEC-II for Intermediate-risk Non-muscle-invasive Bladder Cancer: Is This a Dead End for Mitomycin C Hyperthermia?Clara Cerrato, Morgan Roupret, Maria Carmen Mir
European Urology Oncology|November 19, 2025
Circulating Tumor DNA in Muscle-invasive Bladder Cancer: Promise, Pitfalls, and Path ForwardClara Cerrato, Morgan Rouprêt, Maria Carmen Mir
European Urology|April 2, 2013
Words of wisdom: Re: Precise segmental renal artery clamping under the guidance of dual-source computed tomography angiography during laparoscopic partial nephrectomyMaria Carmen Mir, Rebecca Campbell, Steven C Campbell
Urology|June 10, 2014
Editorial commentSteven C Campbell, Maria Carmen Mir, Toshio Takagi
European Urology|May 23, 2017
Reply to Jae Heon Kim and Benjamin I. Chung's Letter to the Editor re: Maria Carmen Mir, Ithaar Derweesh, Francesco Porpiglia, Homayoun Zargar, Alexandre Mottrie, Riccardo Autorino. Partial Nephrectomy Versus Radical Nephrectomy for Clinical T1b and T2 Renal Tumors: A Systematic Review and Meta-analysis of Comparative Studies. Eur Urol 2017;71:606-17Maria Carmen Mir, Ithaar H Derweesh, Riccardo Autorino
European Urology Oncology|April 4, 2026
Re: Bertolo R, Pastore AL, Verze P, et al. Real-world Burden and Management of Late Genitourinary Toxicity after Prostate Radiotherapy: Insights from IRRADIaTE, the Italian Registry of Radiotherapy-associated Disorders and Urological Treatment & Evaluation. Eur Urol Oncol. In press. http://dx.doi.org/10.1016/j.euo.2026.01.005Shilpa Gupta, Maria Carmen Mir, Daniel E Spratt
Pageof 7